Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 18/20 | 0.55 |
| ▸ | GSK3B | P49841 | 13/20 | 0.55 |
| ▸ | WNT1 | P04628 | 12/20 | 0.55 |
| ▸ | CLK2 | P49760 | 3/20 | 0.55 |
| ▸ | CLK3 | P49761 | 3/20 | 0.55 |
| ▸ | PLAU | P00749 | 1/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19540426 | 0.84 | DYRK1A (0.69) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL23916209 | 0.80 | DYRK1A (0.53) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL19540243 | 0.76 | DYRK1A (0.66) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL23916344 | 0.76 | DYRK1A (0.66) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL19540166 | 0.76 | DYRK1A (0.74) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL19540446 | 0.75 | DYRK1A (0.77) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL19540451 | 0.75 | DYRK1A (0.79) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL19540380 | 0.75 | DYRK1A (0.64) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL19540267 | 0.75 | DYRK1A (0.85) | DYRK1AGSK3BWNT1CLK2CLK3 | |
| SCHEMBL23916869 | 0.74 | DYRK1A (0.65) | DYRK1AGSK3BWNT1CLK2CLK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3892276-A1 | ISOQUINOLIN-3-YL CARBOXAMIDES AS WNT INHIBITORS | BioSplice Therapeutics, Inc. (US) | 2021-10-13 | — | — | EP | disclosed |